Autologous Dendritic Cell

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer
Tomasz M Beer, Nicholas Vogelzang, Jiřina Bartůňková, Kurt Miller, William Oh, Stephane Oudard, Hardev Pandha, A Oliver Sartor, Radek Špíšek, Timothy O Toole, Niels G Borgstein, Winald R Gerritsen

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P164; DOI: 10.1186/2051-1426-3-S2-P164
Density of immunogenic antigens does not explain presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma
Yuanyuan Zha, Stefani Spranger, Kyle M Hernandez, Yan Li, Riyue Bao, Peter Alexieff, Jorge Andrade, Jason J Luke, Thomas F Gajewski

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P425; DOI: 10.1186/2051-1426-3-S2-P425
PD-L1 expression correlates with immune response in a Phase I trial of CCL21 gene modified dendritic cell therapy in lung cancer
Jay M Lee, Edward B Garon, Mi-Heon Lee, Gerald Wang, Dörthe Schaue, Felicita Baratelli, Fereidoun Abtin, Robert Suh, William D Wallace, Gang Zeng, Sherven Sharma, Steven M Dubinett

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) O20; DOI: 10.1186/2051-1426-2-S3-O20
Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1
Sharron Gargosky, Canvas Clinical Team

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P72; DOI: 10.1186/2051-1426-2-S3-P72
Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
Michael Bayer, Xiaojin Wang, Chengwei Chen, Xiaosong Chen, Qingchun Fu, Jia He, William Cao, Craig Fredrickson, Jessica Cannon, Andrew Cornforth, Gabriel Nistor, Robert Dillman

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P44; DOI: 10.1186/2051-1426-2-S3-P44
Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer
Lana E Kandalaft, Cheryl Chiang, Emese Zsiros, Janos Tanyi, Daniel Powell, Rosemarie Mick, George Coukos

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P220; DOI: 10.1186/2051-1426-1-S1-P220
P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
C Dargel, M Bassani-Sternberg, K Krebs, S Wilde, D Schendel, DH Busch, M Mann, U Protzer

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) P38; DOI: 10.1186/2051-1426-2-S2-P38

Log in using your username and password

Main menu

Log in using your username and password

You are here

Autologous Dendritic Cell